Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation - Wikidata - wikimedia - TriplyDB

Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation

Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation

http://www.wikidata.org/entity/Q36604919

about

Small-molecule SMAC mimetics as new cancer therapeutics Targeting tumor-stromal interactions in bone metastasis Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.MTA1--a stress response protein: a master regulator of gene expression and cancer cell behavior.Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.JBO-Launched and flying ahead.Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.Osteoclasts-Key Players in Skeletal Health and Disease.IAP proteins as targets for drug development in oncology Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer.Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale.Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitro.RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells.Necroptosis in cancer: An angel or a demon?Reasons for cancer metastasis: A holistic perspective.Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy.Chromosomal instability drives metastasis through a cytosolic DNA response.The Biology of Bone Metastasis.Supramolecular assemblies of histidinylated β-cyclodextrin for enhanced oligopeptide delivery into osteoclast precursors.

P2860

Q26864204-988F9207-CB6D-410A-8BAE-794ECF193D10 Q27024561-A3C78BD8-5A6D-4FD5-8A4A-8FD37D7EB4C0 Q33589984-9C2AEABC-10D2-4863-AD98-E0BC06D36A7C Q33841579-9EBC8268-49F3-4181-AAC9-29384EB87C8F Q33875590-533374E5-B196-43BF-BE73-89EAFAC2D041 Q34573808-2FA8A175-2155-4203-9A29-32B4FE307934 Q35262038-BFA69E9B-C6FF-4E28-B66C-7D10855956F3 Q36491450-EA6FA761-5402-40F3-81AA-6910B52BDF47 Q36637550-8DBD5063-C479-45B3-9059-5BA8B08530BE Q36863121-C8F9AA0F-B891-4706-8320-EBF03CC82258 Q37036135-D0625BF7-45AF-4C0E-B216-96BCB3F860F5 Q37209606-43D6137C-EADA-4C38-811E-39AE13157AD1 Q37279268-8A54F500-C2E1-4953-B27E-C40AF7C96A70 Q37654710-5C11F4E3-63C4-4968-B86E-828A001AC810 Q38927472-670619F4-536F-40C3-AB51-E0C29BF0CEEC Q39102672-AC27D8E7-3000-4A5A-95CD-86068D3D9AEB Q39398933-8C91FE5F-3BFE-4E97-8ED9-DBE5E4BDD464 Q42769364-5C49C1B0-49A5-4793-B76F-76498347D9A0 Q42949488-9F5769F3-F271-4188-8052-77559E30D499 Q50001777-433749FB-AC67-4E5B-9EC3-1137800A2C2A Q50175870-8D64C7D2-D156-43CA-A792-497DA4541140 Q51499839-D64E1460-CFEB-430C-8021-27C805F51369

P2860

Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation

http://www.wikidata.org/entity/Q36604919

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Antagonism of inhibitor of apo ...... expected osteoclast activation

@ast

Antagonism of inhibitor of apo ...... expected osteoclast activation

@en

type

label

Antagonism of inhibitor of apo ...... expected osteoclast activation

@ast

Antagonism of inhibitor of apo ...... expected osteoclast activation

@en

prefLabel

Antagonism of inhibitor of apo ...... expected osteoclast activation

@ast

Antagonism of inhibitor of apo ...... expected osteoclast activation

@en

P1433

Q36604919-0DCCC6FB-39CA-4081-A092-68339CEDF6D7

P1476

Q36604919-04FF6640-52BB-4819-BDCD-B55AC1242A52

P2093

Q36604919-0A3A209A-367A-4008-BD81-F0D7C90D8C3F

Q36604919-19235C1C-6575-44FA-A56D-DB4A179A8828

Q36604919-4178C61A-732A-4F4E-B228-5552EECF6755

Q36604919-566B0961-F3C6-4A75-92CC-8454CD7EF393

Q36604919-5F14F239-EC82-494E-95A7-440838EAD7A4

Q36604919-6B70854F-F527-40B2-AF02-AED8EEC2B490

Q36604919-6F42734D-2AF5-4594-B378-701F7E11FA19

Q36604919-7C9829CA-0675-4FB0-B3C4-A19A332A710D

Q36604919-894415E6-5A32-4180-87F1-8B0344B15829

Q36604919-A13DBBBC-45D0-4D38-ADA4-D09EB8785C94

P2860

Q36604919-0197A45C-2880-4278-A921-437CDE35DDD1

Q36604919-07C7BD35-9325-48DA-B927-98658B0A8B84

Q36604919-0DBF39A4-1368-4F4A-9BEB-637636310F40

Q36604919-104B4B0A-EA1C-43F6-909A-43240EE67B3D

Q36604919-1615C711-996F-4D16-BE00-9257A81F67DE

Q36604919-19B9B14B-4092-4D9F-993F-A9C471AABBF3

Q36604919-19FA9F8B-B3B0-4F1A-AFC3-44EB2561A3CF

Q36604919-2C2E550C-3A4E-44F3-B33C-4D39D6DB8E4E

Q36604919-2D443F19-3F5A-4AC5-B94F-C2B179BA6877

Q36604919-312C1890-1CF5-4D00-BD77-9A1083611293

P304

Q36604919-8D746EFF-FBD4-4E6F-B370-C81471167952

P31

Q36604919-AD6ADDD5-AC9B-4EEF-8E44-0DA05B1C4A1C

P356

Q36604919-5794A155-B087-4468-9491-8488FC3BCED8

P433

Q36604919-881C15A2-EEF6-4C4F-AE9E-87934FA5A74D

P478

Q36604919-5D0D79BE-07B8-4FC7-A6EF-CA83FE74CE72

P50

Q36604919-BE7B2155-1C1D-488D-A35F-024EEC956667

P577

Q36604919-B1FF15D6-C929-4715-8B09-171437B5E333

P698

Q36604919-6E3A930F-E72B-46A5-84F8-3B7A8D3F3B57

P932

Q36604919-3216930D-0268-4025-B762-64017F299D79

P356

2159-8290.CD-12-0271

P1433

Cancer Discovery

P1476

Antagonism of inhibitor of apo ...... expected osteoclast activation

@en

P2093

Chang Yang

http://www.w3.org/2001/XMLSchema#string

David Piwnica-Worms

http://www.w3.org/2001/XMLSchema#string

Jennifer L Davis

http://www.w3.org/2001/XMLSchema#string

Katherine N Weilbaecher

http://www.w3.org/2001/XMLSchema#string

Lynne I Collins

http://www.w3.org/2001/XMLSchema#string

Paras Vora

http://www.w3.org/2001/XMLSchema#string

Robert H Mach

http://www.w3.org/2001/XMLSchema#string

Roberta Faccio

http://www.w3.org/2001/XMLSchema#string

Rong Zeng

http://www.w3.org/2001/XMLSchema#string

Suwanna Vangveravong

http://www.w3.org/2001/XMLSchema#string

P2860

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation

Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner

CXCR4 regulates growth of both primary and metastatic breast cancer

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Regulation and function of NF-kappaB transcription factors in the immune system

NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis.

NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis

P304

212-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-12-0271

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Deborah V Novack

P577

2012-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23269702

http://www.w3.org/2001/XMLSchema#string

P932

3570610

http://www.w3.org/2001/XMLSchema#string